22.09.2015 Views

Q Q

1W4tWaq

1W4tWaq

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

I. Ruiz-Camps, et al.<br />

Infecciones por hongos filamentosos en el paciente inmunosuprimido: profilaxis y tratamiento<br />

BIBLIOGRAFIA<br />

1. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens<br />

N. Risk assessment and prognostic factors for mould-related<br />

diseases in immunocompromised patients. J Antimicrob Chemother<br />

2011; 66 Suppl 1: i5-14.<br />

2. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis.<br />

Thorax 2015; 70: 270-7.<br />

3. Vallejo Llamas JC, Ruiz-Camps I. Invasive fungal infection in haematology<br />

patients. Enferm Infecc Microbiol Clin 2012; 30: 572-9.<br />

4. Peghin M, Ruiz-Camps I, Garcia-Vidal C, Cervera C, Andreu J, Martin<br />

M, et al. Unusual forms of subacute invasive pulmonary aspergillosis<br />

in patients with solid tumors. J Infect. 2014; 69: 387-95.<br />

5. Ruiz-Camps I, Aguado JM, Almirante B, Bouza E, Ferrer-Barbera CF,<br />

Len O, et al for GEMICOMED (Medical Mycology Study Group of<br />

SEIMC). Guidelines for the prevention of invasive mould diseases<br />

caused by filamentous fungi by the Spanish Society of Infectious<br />

Diseases and Clinical Microbiology (SEIMC). Clin Microbiol Infect<br />

2011; 17 Suppl 2:1-24.<br />

6. Duarte RF, Sánchez-Ortega I, Cuesta I, Arnan M, Patiño B, Fernández<br />

de Sevilla A, et al.. Serum galactomannan-based early detection<br />

of invasive aspergillosis in hematology patients receiving effective<br />

antimold prophylaxis. Clin Infect Dis. 2014; 59: 1696-1702.<br />

7. Ruiz-Camps I, Jarque I. Invasive mould disease in haematological<br />

patients. Rev Iberoam Micol 2014; 31: 249-54.<br />

8. Vallejo C, Vázquez L, Cabrera Martín JR, Carreras E, García Rodríguez<br />

J, Ruiz Camps I, et al. Treatment of invasive fungal infections<br />

in high-risk haematological patients: what have we learnt in the<br />

past 10 years? Rev Esp Quimioter 2013 ; 26: 378-86.<br />

9. Nucci M, Anaissie E. How we treat invasive fungal diseases in patients<br />

with acute leukemia: the importance of an individualized<br />

approach. Blood. 2014; 124: 3858-3869<br />

10. Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely<br />

OA, et al. Combination antifungal therapy for invasive aspergillosis:<br />

a randomized trial. Ann Intern Med 2015; 162: 81-9.<br />

11. Herbrecht R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V. Risk<br />

stratification for invasive aspergillosis in immunocompromised patients.<br />

Ann N Y Acad Sci 2012;1272:23-30.<br />

Rev Esp Quimioter 2015; 28 (Suppl. 1): 38-42 42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!